Sex Reassignment Surgery Market Size

Request Free Sample Copy

Report ID: 6222
Published Date: Sep 17, 2025
Report Format: PDF, PPT

Buy Now

Sex Reassignment Surgery Market Outlook:

Sex Reassignment Surgery Market size was over USD 1 billion in 2025 and is projected to reach USD 2.92 billion by 2035, witnessing around 11.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of sex reassignment surgery is evaluated at USD 1.1 billion.

The sex reassignment surgery market is influenced by the surge in the prevalence of gender dysphoria. According to Cedars-Sinai's study, the transgender women's first general memory and first encounter with gender dysphoria occurred, on average, 4.5 and 6.7 years ago, respectively. They were 4.7 and 6.2 years for transsexual men, respectively. Also, gender dysphoria was initially experienced by 73% of transgender women and 78% of transgender males by the age of 7.

Browse key industry insights with market data tables & charts from the report:

Sex Reassignment Surgery Market Size, Share & Industry Forecast 2035

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of sex reassignment surgery is evaluated at USD 1.1 billion.

The global sex reassignment surgery market size was worth over USD 1 billion in 2025 and is poised to witness a CAGR of more than 11.3%, crossing USD 2.92 billion revenue by 2035.

Europe sex reassignment surgery market is anticipated to capture 35% share by 2035, driven by the rise in disposable income inspiring gender change surgeries.

Key players in the market include Bupa Group, Mayo Clinic, Amish Hospital, Boston Medical Center, Cleveland Clinic, Transgender Surgery Institute, Plastic Surgery Group of Rochester, The Johns Hopkins University, IM Gender Clinic, GRS Montreal Clinic.